Bromocriptine
Indications: - Other specified benign neoplasm of endocrine glands Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Octreotide
Vendor: Marketplace supplier
Formulations:
- Parenteral > General injections > IM: 20 mg in vial (modified-release, as acetate) plus diluent
Parenteral > General injections > SC: 0.05 mg per mL in 1 mL vial (immediate-release, as acetate); 0.1 mg per mL in 1 mL vial (immediate-release, as acetate); 0.5 mg per mL in 1 mL vial (immediate-release, as acetate)
Indications:
- Acromegaly or pituitary gigantism
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Parenteral > General injections > IM: 20 mg in vial (modified-release, as acetate) plus diluent
Parenteral > General injections > SC: 0.05 mg per mL in 1 mL vial (immediate-release, as acetate); 0.1 mg per mL in 1 mL vial (immediate-release, as acetate); 0.5 mg per mL in 1 mL vial (immediate-release, as acetate)
Indications:
- Acromegaly or pituitary gigantism
Source: EML workbook import
Similar Products
Cabergoline
Formulations: - Oral > Solid > tablet: 0.5 mg; 1 mg Indications: - Other specified benign neoplasm of endocrine glands Source: EML workbook import
MOQ: 1
Kes0.00
Carbetocin
Formulations: - Parenteral > General injections > IV: 100 µg per mL (heat stable) Indications: - Postpartum haemorrhage Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.